Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer

Stopped early · Phase 2

Conditions studied: Prostatic Neoplasms

In brief

This trial represents an attempt to offer second line immunotherapy plus chemotherapy to patients who have failed prior taxane base therapy.

Key facts

Study ID

NCT00447473

Run by

The Methodist Hospital Research Institute

People needed

31

Starts

2006-07-01

Expected to finish

2008-09-01

Last updated by the study team

2016-03-17

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Baylor College of Medicine - Methodist Hospital — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.